Glucose Biosensors Market Size, Share & Trends Analysis Report By Type (Electrochemical Biosensors, Optical Biosensors), By End-use, By Region, And Segment Forecasts, 2024 - 2030
Glucose Biosensors Market Growth & Trends
The global glucose biosensor market size is expected to reach USD 20.1 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.2% from 2024 to 2030. Glucose biosensors are an essential part of glucose monitoring systems that aid in monitoring blood glucose concentration in diabetic patients, which, in turn, helps them to manage and control diabetes and avoid any further complications. The International Diabetes Federation stated that in 2021, 537 million people were diagnosed with diabetes, and the number is anticipated to reach 783 million by 2045.
Emerging innovations in glucose monitoring are expanding the market. Glucose biosensors that use different body fluids such as sweat, blood, saliva, and tear and can be calibrated, are being increasingly researched. For instance, in October 2021, Penn State University researchers invented a novel technique that can assess glucose in sweat rather than blood, thus removing the need for a needle prick.
The market's prominent competitors are taking different initiatives such as funding and acquisitions of medium and small-sized businesses, in order to expand their product portfolio and enhance their manufacturing capacity. For instance, in August 2020, Senseonics Holdings entered into a strategic partnership with PHC Holdings Corporation and Ascensia Diabetes Care. This allowed Ascensia to be the exclusive global distribution partner for Senseonics' CGM systems.
Glucose Biosensors Market Report Highlights
- By type, the electrochemical biosensor segment accounted for the largest revenue share in 2023 owing to its sensitivity, reproducibility, and ease of maintenance
- The hospital end-use segment held the largest revenue share in 2023, owing to the extensive use of glucose biosensors in hospital settings and an increase in the number of patients visiting hospitals with diabetes.
- North America accounted for the largest revenue share in 2023. Asia Pacific is anticipated to expand at the fastest CAGR during the forecast period, owing to the improved healthcare facilities and reimbursement policies
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1. Segment Definitions
- 1.1.1. Type
- 1.1.2. End-use
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecasts timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR’s internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Volume price analysis (Model 2)
- 1.6.4. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. End-use outlook
- 2.3. Regional outlook
- 2.4. Competitive Insights
- Chapter 3. Glucose Biosensors Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing incidence of diabetes
- 3.2.1.2. Rising demand for minimally and small sized glucose monitoring devices
- 3.2.1.3. Growing patient awareness
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Presence of alternative method
- 3.3. Glucose Biosensors Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
- Chapter 4. Glucose Biosensors Market: Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Glucose Biosensors Market: Type Movement Analysis
- 4.3. Glucose Biosensors Market by Type Outlook (USD Million)
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5. Electrochemical Biosensor
- 4.5.1. Electrochemical Biosensor Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Optical Biosensor
- 4.6.1. Optical Biosensor Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7. Others
- 4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 5. Glucose Biosensors Market: End-use Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Glucose Biosensors Market: End-use Movement Analysis
- 5.3. Glucose Biosensors Market by End-use Outlook (USD Million)
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5. Hospitals
- 5.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Homecare
- 5.6.1. Homecare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7. Diagnostic Centers
- 5.7.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 6. Glucose Biosensors Market: Regional Estimates & Trend Analysis
- 6.1. Regional Dashboard
- 6.2. Regional Glucose Biosensors Market Movement Analysis
- 6.3. Glucose Biosensors Market: Regional Estimates & Trend Analysis by Technology & End Use
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5. North America
- 6.5.1. North America Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.2. U.S.
- 6.5.2.1. Key Country Dynamics
- 6.5.2.2. Competitive Scenario
- 6.5.2.3. Regulatory Framework
- 6.5.2.4. Reimbursement scenario
- 6.5.2.5. U.S. Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.3. Canada
- 6.5.3.1. Key Country Dynamics
- 6.5.3.2. Competitive Scenario
- 6.5.3.3. Regulatory Framework
- 6.5.3.4. Reimbursement scenario
- 6.5.3.5. Canada Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.4. Europe
- 6.5.5. Europe Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.6. UK
- 6.5.6.1. Key Country Dynamics
- 6.5.6.2. Competitive Scenario
- 6.5.6.3. Regulatory Framework
- 6.5.6.4. Reimbursement scenario
- 6.5.6.5. UK Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.7. Germany
- 6.5.7.1. Key Country Dynamics
- 6.5.7.2. Competitive Scenario
- 6.5.7.3. Regulatory Framework
- 6.5.7.4. Reimbursement scenario
- 6.5.7.5. Germany Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.8. France
- 6.5.8.1. Key Country Dynamics
- 6.5.8.2. Competitive Scenario
- 6.5.8.3. Regulatory Framework
- 6.5.8.4. Reimbursement scenario
- 6.5.8.5. France Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.9. Italy
- 6.5.9.1. Key Country Dynamics
- 6.5.9.2. Competitive Scenario
- 6.5.9.3. Regulatory Framework
- 6.5.9.4. Reimbursement scenario
- 6.5.9.5. Italy Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.10. Spain
- 6.5.10.1. Key Country Dynamics
- 6.5.10.2. Competitive Scenario
- 6.5.10.3. Regulatory Framework
- 6.5.10.4. Reimbursement scenario
- 6.5.10.5. Spain Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.11. Denmark
- 6.5.11.1. Key Country Dynamics
- 6.5.11.2. Competitive Scenario
- 6.5.11.3. Regulatory Framework
- 6.5.11.4. Reimbursement scenario
- 6.5.11.5. Denmark Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.12. Sweden
- 6.5.12.1. Key Country Dynamics
- 6.5.12.2. Competitive Scenario
- 6.5.12.3. Regulatory Framework
- 6.5.12.4. Reimbursement scenario
- 6.5.12.5. Sweden Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.13. Norway
- 6.5.13.1. Key Country Dynamics
- 6.5.13.2. Competitive Scenario
- 6.5.13.3. Regulatory Framework
- 6.5.13.4. Reimbursement scenario
- 6.5.13.5. Norway Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Asia Pacific
- 6.6.1. Asia Pacific Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.2. Japan
- 6.6.2.1. Key Country Dynamics
- 6.6.2.2. Competitive Scenario
- 6.6.2.3. Regulatory Framework
- 6.6.2.4. Reimbursement scenario
- 6.6.2.5. Japan Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.3. China
- 6.6.3.1. Key Country Dynamics
- 6.6.3.2. Competitive Scenario
- 6.6.3.3. Regulatory Framework
- 6.6.3.4. Reimbursement scenario
- 6.6.3.5. China Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.4. India
- 6.6.4.1. Key Country Dynamics
- 6.6.4.2. Competitive Scenario
- 6.6.4.3. Regulatory Framework
- 6.6.4.4. Reimbursement scenario
- 6.6.4.5. India Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.5. South Korea
- 6.6.5.1. Key Country Dynamics
- 6.6.5.2. Competitive Scenario
- 6.6.5.3. Regulatory Framework
- 6.6.5.4. Reimbursement scenario
- 6.6.5.5. South Korea Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.6. Australia
- 6.6.6.1. Key Country Dynamics
- 6.6.6.2. Competitive Scenario
- 6.6.6.3. Regulatory Framework
- 6.6.6.4. Reimbursement scenario
- 6.6.6.5. Australia Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.7. Thailand
- 6.6.7.1. Key Country Dynamics
- 6.6.7.2. Competitive Scenario
- 6.6.7.3. Regulatory Framework
- 6.6.7.4. Reimbursement scenario
- 6.6.7.5. Thailand Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7. Latin America
- 6.7.1. Latin America Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7.2. Brazil
- 6.7.2.1. Key Country Dynamics
- 6.7.2.2. Competitive Scenario
- 6.7.2.3. Regulatory Framework
- 6.7.2.4. Reimbursement scenario
- 6.7.2.5. Brazil Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7.3. Mexico
- 6.7.3.1. Key Country Dynamics
- 6.7.3.2. Competitive Scenario
- 6.7.3.3. Regulatory Framework
- 6.7.3.4. Reimbursement scenario
- 6.7.3.5. Mexico Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7.4. Argentina
- 6.7.4.1. Key Country Dynamics
- 6.7.4.2. Competitive Scenario
- 6.7.4.3. Regulatory Framework
- 6.7.4.4. Reimbursement scenario
- 6.7.4.5. Argentina Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8. Middle East & Africa
- 6.8.1. Middle East & Africa Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8.2. South Africa
- 6.8.2.1. Key Country Dynamics
- 6.8.2.2. Competitive Scenario
- 6.8.2.3. Regulatory Framework
- 6.8.2.4. Reimbursement scenario
- 6.8.2.5. South Africa Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8.3. Saudi Arabia
- 6.8.3.1. Key Country Dynamics
- 6.8.3.2. Competitive Scenario
- 6.8.3.3. Regulatory Framework
- 6.8.3.4. Reimbursement scenario
- 6.8.3.5. Saudi Arabia Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8.4. UAE
- 6.8.4.1. Key Country Dynamics
- 6.8.4.2. Competitive Scenario
- 6.8.4.3. Regulatory Framework
- 6.8.4.4. Reimbursement scenario
- 6.8.4.5. UAE Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8.5. Kuwait
- 6.8.5.1. Key Country Dynamics
- 6.8.5.2. Competitive Scenario
- 6.8.5.3. Regulatory Framework
- 6.8.5.4. Reimbursement scenario
- 6.8.5.5. Kuwait Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 7. Competitive Landscape
- 7.1. Market Participant Categorization
- 7.2. Key Company Profiles
- 7.2.1. Abbott Laboratories
- 7.2.1.1. Company overview
- 7.2.1.2. Financial performance
- 7.2.1.3. Product benchmarking
- 7.2.1.4. Strategic initiatives
- 7.2.2. Dexcom
- 7.2.2.1. Company overview
- 7.2.2.2. Financial performance
- 7.2.2.3. Product benchmarking
- 7.2.2.4. Strategic initiatives
- 7.2.3. Ascenia Diabetes Care
- 7.2.3.1. Company overview
- 7.2.3.2. Financial performance
- 7.2.3.3. Product benchmarking
- 7.2.3.4. Strategic initiatives
- 7.2.4. Nova Diabetes Care
- 7.2.4.1. Company overview
- 7.2.4.2. Financial performance
- 7.2.4.3. Product benchmarking
- 7.2.4.4. Strategic initiatives
- 7.2.5. F. Hoffmann-La Roche AG
- 7.2.5.1. Company overview
- 7.2.5.2. Financial performance
- 7.2.5.3. Product benchmarking
- 7.2.5.4. Strategic initiatives
- 7.2.6. Sanofi
- 7.2.6.1. Company overview
- 7.2.6.2. Financial performance
- 7.2.6.3. Product benchmarking
- 7.2.6.4. Strategic initiatives
- 7.2.7. GlySens Incorporated
- 7.2.7.1. Company overview
- 7.2.7.2. Financial performance
- 7.2.7.3. Product benchmarking
- 7.2.7.4. Strategic initiatives
- 7.2.8. Trividia Health
- 7.2.8.1. Company overview
- 7.2.8.2. Financial performance
- 7.2.8.3. Product benchmarking
- 7.2.8.4. Strategic initiatives
- 7.2.9. Bayer
- 7.2.9.1. Company overview
- 7.2.9.2. Financial performance
- 7.2.9.3. Product benchmarking
- 7.2.9.4. Strategic initiatives
- 7.2.10. Lifescan
- 7.2.10.1. Company overview
- 7.2.10.2. Financial performance
- 7.2.10.3. Product benchmarking
- 7.2.10.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook